Financial Daily from THE HINDU group of publications
Tuesday, Feb 28, 2006


Group Sites

Industry & Economy - Health

Will Budget bring relief to cancer, AIDS patients?

P.T. Jyothi Datta

Mumbai , Feb. 27

There could be some relief for patients suffering from cancer and AIDS, if Budget 2006 does indeed slash the different duties on critical drugs for treating these conditions.

The apex Chemicals and Fertilisers Ministry has proposed Customs and excise duty cuts on over 75 cancer treatment drugs and 30-plus anti-AIDS drugs to make them affordable, a Ministry official told Business Line.

Cisplatin and carboplatin (used for chemotheraphy), azathioprine, interferon, melphalan, morphine sulphate, and pacitaxel are just some of the cancer drugs that have been recommended for zero duty.

Nevirapine, the medicine given to a HIV-affected mothers to prevent them from transmitting the ailment to infants, stavudine, saquinavir, lamivudine-zidovudine combination drug, indinavir, etc., are some of the anti-AIDS drugs listed by the Ministry.

At a recent meeting of the National AIDS Council, chaired by the Prime Minister, Dr Manmohan Singh, it was also suggested that the public sector drug companies make the first-line AIDS drugs that are off patent.

These drugs would be supplied to the National Aids Control Organisation, which spearheads the rollout of anti-AIDS drugs through hospitals across the country, the official said.

While India has an estimated 5.1 million people suffering from HIV/AIDS, according to the draft Pharmaceutical Policy, at any point about 25 lakh people suffer from cancer in the country.

A conservative estimate of Rs 25,000 spent on cancer drugs per patient would require about Rs 5,000 crore worth of drugs.

But the current turnover of the segment is only about Rs 150 crore. This gap makes the drugs unaffordable, the official said.

While it will be revealed tomorrow whether the recommended list of cancer and AIDS drugs did make it to the Budget final print, the Ministry subsequently looks to take its recommendation to the next level - States will then be asked to exempt these drugs from VAT, the official said.

More Stories on : Health | Pharmaceuticals | Budget | Excise and Customs

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Economic Survey proposes reforms in tax system
Pegs growth rate at 8.1 per cent; cites crude prices as a risk factor

Interest rates may firm up: Survey
`Forex reserves accretion slowing, credit offtake keeps rising'

`Rapid, bold policy responses needed to manage oil crisis'
Petro-product pricing crucial to fiscal health

`Follow China model on labour market'
Revisit costs incurred on anti-poverty schemes

Delhi, Mumbai airports revamp to begin mid-year
`In-principle' decision on Chennai airport revamp taken

Textile sector registers `moderate' export growth
Lags behind China in tapping free quota regime

Govt told to clarify rationale for postal subsidy
`Auto exports stay untapped'
Need for reforming labour laws stressed
Learn lessons from the Chinese model, says Survey

Govt sure of reining in inflation at 5 pc
Urban infrastructure: Call for user-charge approach
Smaller cities find the going tough due to financial crunch

Broadband is the next frontier
All States told to implement VAT
Contracts for stretches under NHDP to be awarded soon
India Inc says it's pragmatic
How critical is rural employment?
To bridge urban-rural divide

Automotive testing unit in Assam launched — Facilities to be used for N-E
JK Cement fixes IPO price at Rs 148
Food subsidy growth seen at 1.55 pc
Fertiliser subsidy to exceed Budget estimates
Total subsidy may cross Rs 24,000 crore

`Growth outlook bright'
Core sector growth slows to 3.3% in Jan
India Inc positive on growth: Survey
EU move to boost carbon trading — All flights must buy credits to offset GHC emissions
Indo-Arab meet begins — IT, medical tourism, bio-tech thrust areas
Three more Bio-safety Level 3 labs
Will Budget bring relief to cancer, AIDS patients?
Reconsider airport update plans: Panel
KCCI to identify developers for multi-product component in SEZ
Panel to decide on gas transmission tariff of GAIL
Gas supply issue: Meet today to resolve deadlock
Chiefs of Panna-Mukta venture partners, GAIL to participate

High credit rating for ONGC bonds
CDC supplies diagnostic reagents for bird flu investigation
Pharma industry clocks healthy growth
Leverage strengths in organic synthesis, process engineering

NPPA recovers Rs 99 cr from drug cos
Concern over power sector
`Electricity to all houses'
Sponge iron issues
Misplaced optimism?
Sugar output figures

Will Budget dilute FBT provisions, usher in EET?
Lower level of peak customs duty, rationalisation of duties for petroleum industry likely

Cotton growers worried over likely duty cut
Textile industry seeks special rules of origin provisions
NTPC plans joint venture with Coal India
AC to beat bird flu?
Food processing: Govt bid to woo big biz houses
Foundation stone laid for three RPG group projects
Goenkas tie-up with Godrej Group for shopping arcade

IT cos seek tax reliefs
MAIT wants excise anamolies removed

Coimbatore textile fair to feature `China Pavilion'
Over 300 companies covering all segments will be participating

Biotech industry seeks extension of deductions
A touch of glass
Exim Bank to invest $7 m in animated feature film
Rich Crest-Lions Gate's production

Women managers' meet on March 8
Theme inspired by Kalam's vision

`Core sector can absorb $150 b FDI'
ICRISAT partners CII in rural growth plan
TRAI says `end differential tariff'
Goan assessees for changes in I-T Act
I-T Dept to step up vigil against tax offenders

The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright 2006, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line